@prefix ns1: <http://schema.org/> .

{
    <http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=165988> a ns1:MedicalCondition ;
        ns1:alternateName "Hyperinsulinemic hypoglycemia, diazoxide-resistant diffuse form" ;
        ns1:code [ a ns1:MedicalCode ;
                ns1:codeValue "ORPHA:165988" ;
                ns1:codingSystem "ORPHAcode" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "ORPHA:165988" ;
                ns1:codingSystem "ORPHAcode" ] ;
        ns1:description "Diazoxide-resistant diffuse hyperinsulism (DRDH) is a form of Diazoxide resistant hyperinsulinism (see this term) characterized by recurrent episodes of profound hypoglycemia caused by an excessive/ uncontrolled insulin secretion (inappropriate for the level of glycemia) due to diffuse involvement of pancreas that is unresponsive to medical treatment with diazoxide, often necessitating near total/total pancreatectomy." ;
        ns1:epidemiology "Prevalence : " ;
        ns1:identifier "165988" ;
        ns1:name [ a ns1:PronounceableText ;
                ns1:inLanguage "EN" ;
                ns1:textValue "Diazoxide-resistant diffuse hyperinsulinism" ],
            [ a ns1:PronounceableText ;
                ns1:inLanguage "EN" ;
                ns1:textValue "Diazoxide-resistant diffuse hyperinsulinism" ] .
}

